Glasgow, Scotland and Bangalore, India - March 14, 2017:

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company today announced that it has won a twelve-year contract from NHS Scotland to build a next generation Enterprise Master Patient Index (eMPI) solution. NHS Scotland is the region’s National Health Board working towards reducing health inequalities and improving health conditions. This solution, which will be hosted in Scotland, will help NHS Scotland transition from its current legacy Community Health Index System (CHI) to offer cost effective, efficient, paperless and patient-friendly healthcare services in Scotland.

Wipro has partnered with NextGate for this project. Wipro will leverage NextGate’s award-winning MatchMetrix^® platform so as to enable the eMPI solution to link and manage data from patients, partner institutions and third party organizations.

In line with NHS’ future requirements, Wipro with NextGate will build a scalable solution to enable healthcare providers in the Scottish healthcare boards to maintain unique patient identifiers. The solution based on NextGate’s MatchMetrix platform, will integrate with other existing NHS Scotland legacy systems. It has the ability to compare patient records from disparate applications, and link together multiple patient records for simplified and accurate cross-platform validation of patient data. The solution increases efficiency by reducing time spent on searching for patient information, freeing up resources to focus on providing safe treatment.

"We are pleased to be working with Wipro, a leading global information technology company and NextGate, the leader in healthcare identity management, to move our Mainframe Solutions Transformation Programme (MSTP) initiative forward," said Andy Robertson, Director of IT at NHS, National Services Scotland. He added, "The modernization of our CHI system using their technology will help us deliver the highest standards of healthcare to the people of Scotland in a cost effective and efficient manner."

Jeffrey Heenan Jalil, Senior Vice-President and Global Head, Healthcare, Life Sciences & Services, Wipro Limited said, “We are delighted to have been selected as a partner by NHS Scotland and believe that this initiative is a step towards efficient data management to provide improved quality and integrated care. Wipro understands that technology is a strategic enabler, and offers ways to improve patient outcomes, expand access, and enhance patient experience. We are investing in building next-generation data management technologies, which will form the backbone to deliver connected and seamless healthcare.”

Andy Aroditis, CEO, NextGate said, “NHS Scotland is taking a visionary approach to the new CHI system. The detailed and comprehensive selection process showed their passionate interest in developing a full-featured, efficient, and supportable solution to drive better information management for the benefit of patient care. NextGate is privileged to contribute our award-winning MatchMetrix® platform and industry expertise to the project, providing the most interoperable and accurate patient identity management technology to support the delivery of comprehensive care.”

About Wipro Limited.
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of "Business through Technology." By combining digital strategy, customer centric design, advanced analytics and product engineering approach, Wipro helps its clients create successful and adaptive businesses. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, Wipro has a dedicated workforce of over 170,000, serving clients across 6 continents. For more information, please visit www.wipro.com

Media Contact:
Shraboni Banerjee
Wipro Limited
Shraboni.banerjee@wipro.com

Forward-looking and Cautionary Statements
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.